Doctor profile · Federal record
Dr. Neil Chevallier, C.R.N.P.
Family Nurse Practitioner (CMS: Nurse Practitioner) · Monroe, LA
- NPI 1063835577
- Accepts Medicare
- 13 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
2409 Broadmoor Blvd
Monroe, LA 712012964
(318) 323-8799
fax (318) 323-8815
Credentials & registration
- NPI registered
- February 2014 — 12 yrs on file
- Profile last updated
- August 14, 2023
- Year of graduation
- 2013 — 13 yrs since
- Specialty taxonomy
- 363LF0000X — NUCC code
- State license (1)
- Louisiana #230616
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1063835577. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
501
Distinct HCPCS
10
Medicare allowed
$30,169
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 122 | 28 | $5 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 86 | 77 | $100 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 79 | 70 | $70 | |
11301 |
Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm | 37 | 37 | $65 | |
11302 |
Shaving of skin growth of body, arms, or legs, 1.1-2.0 cm | 36 | 36 | $100 | |
17000 |
Destruction of precancer skin growth, 1 growth | 32 | 32 | $43 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 27 | 27 | $90 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 26 | 25 | $44 | |
11102 |
Biopsy of related skin growth, first growth | 25 | 24 | $72 | |
11306 |
Shaving of skin growth of scalp, neck, hands, feet, or genitals, 0.6-1.0 cm | 16 | 16 | $77 |
In context: peer comparison
Among 37 peers in Monroe Family Nurse Practitioner, average services per provider: 86. This provider delivers 5.8× the peer median.Open Payments
Industry payments received
All-time total
$1,403
Transactions
65
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Janssen Biotech, INC. | 10 | $331.38 | |
| Genzyme Corporation | 9 | $145.11 | |
| Lilly USA, LLC | 8 | $137.02 | |
| Incyte Corporation | 9 | $134.70 | |
| Sanofi-Aventis U.S. LLC | 1 | $98.99 | |
| Abbvie INC. | 6 | $96.73 | |
| Leo Pharma INC. | 4 | $69.08 | |
| Regeneron Healthcare Solutions, INC. | 3 | $62.96 | |
| Amgen INC. | 3 | $44.84 | |
| Arcutis Biotherapeutics, INC. | 2 | $42.18 | |
| Almirall LLC | 2 | $40.07 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | 2 | $37.95 | |
| Galderma Laboratories, L.P. | 2 | $34.31 | |
| Ucb, INC. | 2 | $33.97 | |
| Pfizer INC. | 2 | $31.34 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
373
Patients
187
Total drug cost
$888,365
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Triamcinolone Acetonide | Generic | 70 | 53 | $1,241 |
| Ketoconazole | Generic | 47 | 35 | $1,403 |
| Clobetasol Propionate | Generic | 37 | 27 | $968 |
| Dupixent Pen (Dupilumab) | Brand | 36 | 0 | $138,073 |
| Humira(Cf) Pen (Adalimumab) | Brand | 32 | 0 | $367,412 |
| Fluocinonide | Generic | 28 | 22 | $1,380 |
| Mupirocin | Generic | 25 | 24 | $160 |
| Hydroxyzine Hcl | Generic | 16 | 0 | $78 |
| Clindamycin Phosphate | Generic | 15 | 0 | $543 |
| Fluorouracil | Generic | 15 | 15 | $1,113 |
Frequently asked questions
What is Dr. Neil Chevallier's medical specialty?
Dr. Neil Chevallier practices Family Nurse Practitioner in Monroe, LA.
Where does Dr. Neil Chevallier practice?
Dr. Neil Chevallier practices at 2409 Broadmoor Blvd, Monroe, LA 712012964. Office phone: 3183238799.
What is Dr. Neil Chevallier's NPI?
Dr. Neil Chevallier's National Provider Identifier (NPI) is 1063835577, issued by NPPES.
Does Dr. Neil Chevallier accept Medicare assignment?
Yes. Dr. Neil Chevallier accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Neil Chevallier commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99214); Established patient office or other outpatient visit (HCPCS 99213). Source: CMS Medicare Physician & Other Practitioners file.